ersonal use only

Investor presentation

H1 FY22 results

Raj Naran, Managing Director and CEO

Luis Damasceno, Chief Financial Officer

17 November 2021

Right Solutions Right Partner

www.alsglobal.com

IMPORTANT NOTICE AND DISCLAIMER

- This presentation has been prepared by ALS Limited, (ALS or the Company). It contains general information about the Company's activities as at the date of the

only

presentation. It is information given in summary form and does not purport to be complete. The distribution of this presentation in jurisdictions outside Australia

may be restricted by law, and you should observe any such restrictions.

- This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of securities, or an offer, invitation or

recommendation to sell, or a solicitation of an offer to buy, securities in any jurisdiction. Neither this document nor anything in it shall form the basis of any

contract or commitment. This presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account the

investment objectives, financial situation or needs of any investor. All investors should consider such factors in consultation with a professional advisor of their

use

choosing when deciding if an investment is appropriate.

- The Company has prepared this presentation based on information available to it, including information derived from public sources that have not been

independently verified. No representation or warranty, express or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability

of the information, opinions or conclusions expressed herein.

- This presentation includes forward-looking statements within the meaning of securities laws. Any forward-looking statements involve known and unknown risks

and uncertainties, many of which are outside the control of the Company and its representatives. Forward-looking statements may also be based on estimates and

ersonal

assumptions with respect to future business decisions, which are subject to change. Any statements, assumptions, opinions or conclusions as to future matters

may prove to be incorrect, and actual results, performance or achievement may vary materially from any projections and forward-looking statements.

- Due care and attention should be undertaken when considering and analysing the financial performance of the Company.

- All references to dollars are to Australian currency unless otherwise stated.

2

Investor Presentation. Half Year Results H1 FY22

Right Solutions • Right Partner

Our sustainability programs

ersonal use only

Sustainability vision:

Deliver world-class health and safety outcomes, and attract a diverse, capable and engaged workforce.

People

Minimise our environmental footprint and build our resilience to climate-related impacts.

Environment

Make a positive contribution to our local communities.

Society

Operate ethically and responsibly to deliver sustainable outcomes for our stakeholders.

Governance

Caring for our people through:

A safe and healthy workplace

Positively contributing to society

COVID-19 Testing

Community programs

Extraction of genetic material

Carbon Reduction Plan:

40% reduction in carbon intensity by 2030

40% reduction aligned to limiting global warming to 1.5oC.

Target Alignment

Switch to renewables.

Invest in solar.

Electricity

Vehicle safety and efficiency standard.

Fleet Efficiency

Facilities fit out sustainability standard.

Building Sustainability

3

Our commitment to climate action:

We aim to be carbon neutral in FY23

Investor Presentation. Half Year Results H1 FY22

Right Solutions • Right Partner

ESG program - FY22 progress

People

Health & Safety

Training & Development

Safety Culture/Life Saving Rules

Investing in talent development

Substantial improvement in injury frequency rate.

only

Implementation of Women in Leadership Program.

Diversity & Equality

Innovation & Technology

Respecting differences

Embracing innovation and technology

Supportive Work Environment

Hazard observations reporting substantially increased.

Environment

Commenced installation of 11 solar PV systems for FY2022.

Climate Change

Operational Environmental

Continued rollout of our LED lighting program across our facilities.

CO and Greenhouse Gas emissions

Performance

Task Force on Climate Related Financial

Management of adverse environmental

Disclosures (TCFD)

Commenced procurement of renewable energy across multiple countries.

emissions

Efficient buildings, plant and equipment

use

Efficient operations

Pilot fume cupboard efficiency program in progress.

Waste Reduction

Reduce, reuse, recycle

Society

Economic Contributions

Local Contribution

COVID testing for humans, wastewater and surfaces.

Paying our fair share of tax

Community Sponsorships

Partnering with local schools and universities to promote science

Donations and Sponsorships

ALS Cares

education.

Science Education Programs

Human Rights

Local Employment

ALS Cares workplace giving program.

ersonal

Worker's rights upheld /

Modern Slavery Assessments

Internal training plan on Modern Slavery Risks developed.

Governance

Financial Performance

Regulatory Compliance

Maximise return for shareholders

Systems to maintain legal compliance

Meeting or exceeding Corporations Act and ASX Guideline

Anti-bribery & anti-corruption

requirements.

Conduct & Culture

Data integrity and traceability

Innovation & Technology

External assurance assessment of FY21 Sustainability Report

Ethical business conduct

Strategy, investment & collaboration /

completed.

Service lifecycle management

Enterprise Risk Management

Cybersecurity analysis completed.

Management of external strategic, financial,

and operational risks

4

Investor Presentation. Half Year Results H1 FY22

Right Solutions • Right Partner

Group H1 FY22 performance vs strategic priorities

Shorter-term strategic priorities

H1 FY22 performance

Life Sciences

only

Total revenue growth of +19.0% (+17.8% organic revenue growth)

Strong revenue growth and margin expansion

Underlying EBIT margin of +17.7%, +131 bps vs pcp

Commodities

Strong revenue growth and margin expansion

Total revenue growth of +37.7% (+41.0% organic revenue growth)

Underlying EBIT margin of 29.9%, expansion of +519 bps vs pcp

Increase market-leading position in Geochemistry

+46% sample volume vs pcp, +27% vs H1 FY20

use

Underlying EBIT margin of 33.4%

Industrial

Improve organic revenue growth and stabilise margin

+3.0% organic revenue growth with margin decrease of (199) bps margin vs pcp

Longer-term strategic priorities

H1 FY22 performance

Improve sustainability profile of the Group

Launched climate change policy targeting 40% reduction in scope 1 and 2 emissions by 2030

Aim to be carbon neutral in FY23

Non-cyclical businesses contribute 50% of Group underlying EBIT

48% underlying EBIT contribution in H1 FY22 (56% in H1 FY21)

at the top of the commodity cycle

Strong balance sheet to fund growth of Group

Lowest leverage ratio (1.5x) in 5 years with ~$720m of liquidity available to fund growth

Completion of acquisition of Nuvisan in October 2021 (not included in H1 FY21), significantly expanding

Strategic acquisitions in key growth markets

Pharmaceutical service offering

Highly disciplined acquisition strategy

Investment in technology and innovation

Continued investment across businesses with targeted capex spending on automation, technical

infrastructure (such as 'LIMS' and ERP platforms) and expansion of capacity

5

Investor Presentation. Half Year Results H1 FY22

Right Solutions • Right Partner

ersonal

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

ALS Limited published this content on 16 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2021 22:16:15 UTC.